Multi-Layer Computational Design of Small-Molecule Inhibitors Targeting Nck1 for Autoimmune Disease Treatment
DOI:
https://doi.org/10.54097/x26ype45Keywords:
small molecule inhibitors (SMIs), molecular docking, molecular dynamics (MD), virtual screening, in silico design.Abstract
The adaptor protein Nck1 involved in the T cell CD3 signaling pathway is a promising therapeutic target for the treatment of immune system-related diseases. This study established a multi-layer virtual screening pipeline that integrates compound library generation, molecular docking, pan-assay inference compounds (PAINS) filtration, and free energy calculation from molecular dynamics (MD) simulation to design and sequentially identify promising novel small molecule inhibitors (SMIs) for autoimmune diseases treatment. The compound library consists of 10,149 potential SMIs by performing R group enumeration on a first-in-class SMI of Nck1, AX-024, proven effective in empirical experimentation. The compounds were first screened using molecular docking followed by PAINS analysis to narrow down the design pool for higher level computational modeling and simulations. The remaining compounds were subjected to MD simulations for binding free energy calculation of the SMI-Nck1 systems, which was used to propose top candidates with stable binding. For these candidates, extended MD trajectories were produced to reveal structural mechanics behind their strong performance. Binding mechanism analysis, RMSF profiling, and evaluation of R-group effects identified promising molecules, such as d6294, that consistently outperformed the reference AX-024 in simulations. These analyses revealed key interactions with the Nck1 protein, including salt bridges, cation-π interactions, and hydrogen bonds, that underpin their stability and potential effectiveness. Taken together, this study establishes a transferable pipeline for the in silico design of SMIs and identifies several top candidates with strong potential for subsequent in vitro validation for the treatment of Nck1-related immune system diseases.
Downloads
References
[1] Pisetsky, D.S. (2023) Pathogenesis of autoimmune disease. Nature Reviews Nephrology, 19(8), 509–524. https://doi.org/10.1038/s41581-023-00720-1
[2] Wang, L., Wang, F.-S. and Gershwin, M.E. (2015) Human autoimmune diseases: a comprehensive update. Journal of Internal Medicine, 278(4), 369–395. https://doi.org/10.1111/joim.12395
[3] Katsarou, A., Gudbjörnsdottir, S., Rawshani, A., Dabelea, D., Bonifacio, E., Anderson, B.J., Jacobsen, L.M., Schatz, D.A. and Lernmark, Å. (2017) Type 1 diabetes mellitus. Nature Reviews Disease Primers, 3(1), 17016. https://doi.org/10.1038/nrdp.2017.16
[4] Marrack, P., Kappler, J. and Kotzin, B.L. (2001) Autoimmune disease: why and where it occurs. Nature Medicine, 7(8), 899–905. https://doi.org/10.1038/90935
[5] Song, Y., Li, J. and Wu, Y. (2024) Evolving understanding of autoimmune mechanisms and new therapeutic strategies of autoimmune disorders. Signal Transduction and Targeted Therapy, 9(1), 263. https://doi.org/10.1038/s41392-024-01952-8
[6] Hu, H., Zhang, G., Chen, T., Liu, Y., Meng, L., Holmdahl, R., Dai, L. and Zhao, Y. (2025) Immunosenescence in autoimmune diseases. Autoimmunity Reviews, 24(6), 103805. https://doi.org/10.1016/j.autrev.2025.103805
[7] Pisetsky, D.S. (2023) Pathogenesis of autoimmune disease. Nature Reviews Nephrology, 19(8), 509–524. https://doi.org/10.1038/s41581-023-00720-1
[8] Steinman, L. (2004) Immune Therapy for Autoimmune Diseases. Science, 305(5681), 212–216. https://doi.org/10.1126/science.1099896
[9] Mukherjee, A.B. and Zhang, Z. (2011) Allergic Asthma: Influence of Genetic and Environmental Factors. Journal of Biological Chemistry, 286(38), 32883–32889. https://doi.org/10.1074/jbc.R110.197046
[10] Rolla, G. (2023) Why Current Therapy Does Not Cure Asthma. Is It Time to Move Towards a One Health Approach? Journal of Asthma and Allergy, 16(null), 933–936. https://doi.org/10.2147/JAA.S429646
[11] Chatenoud, L. and Bluestone, J.A. (2007) CD3-specific antibodies: a portal to the treatment of autoimmunity. Nature Reviews Immunology, 7(8), 622–632. https://doi.org/10.1038/nri2134
[12] Borroto, A., Reyes-Garau, D., Jiménez, M.A., Carrasco, E., Moreno, B., Martínez-Pasamar, S., Cortés, J.R., Perona, A., Abia, D., Blanco, S., Fuentes, M., Arellano, I., Lobo, J., Heidarieh, H., Rueda, J., Esteve, P., Cibrián, D., Martinez-Riaño, A., Mendoza, P., Prieto, C., Calleja, E., Oeste, C.L., Orfao, A., Fresno, M., Sánchez-Madrid, F., Alcamí, A., Bovolenta, P., Martín, P., Villoslada, P., Morreale, A., Messeguer, A. and Alarcon, B. (2016) First-in-class inhibitor of the T cell receptor for the treatment of autoimmune diseases. Science Translational Medicine, 8(370), 370ra184-370ra184. https://doi.org/10.1126/ scitranslmed.aaf2140
[13] Atalla, L., Linker-Israeli, M., Steinman, L. and Rao, N.A. (1990) Inhibition of autoimmune uveitis by anti-CD4 antibody. Investigative Ophthalmology & Visual Science, 31(7), 1264–1270.
[14] Raphael, I., Joern, R.R. and Forsthuber, T.G. (2020) Memory CD4+ T Cells in Immunity and Autoimmune Diseases. Cells, 9(3). https://doi.org/10.3390/cells9030531
[15] Gravano, D.M. and Hoyer, K.K. (2013) Promotion and prevention of autoimmune disease by CD8+ T cells. Abul Abbas: An epitome of scholarship, 45, 68–79. https://doi.org/10.1016/j.jaut.2013.06.004
[16] Musette, P. and Bouaziz, J.D. (2018) B Cell Modulation Strategies in Autoimmune Diseases: New Concepts. Frontiers in Immunology, Volume 9-2018. https://www.frontiersin.org/journals/ immunology/ articles/10.3389/fimmu.2018.00622
[17] Lee, D.S.W., Rojas, O.L. and Gommerman, J.L. (2021) B cell depletion therapies in autoimmune disease: advances and mechanistic insights. Nature Reviews Drug Discovery, 20(3), 179–199. https://doi.org/10.1038/s41573-020-00092-2
[18] Serra, P. and Santamaria, P. (2019) Antigen-specific therapeutic approaches for autoimmunity. Nature Biotechnology, 37(3), 238–251. https://doi.org/10.1038/s41587-019-0015-4
[19] Peakman, M. and von Herrath, M. (2010) Antigen-Specific Immunotherapy for Type 1 Diabetes: Maximizing the Potential. Diabetes, 59(9), 2087–2093. https://doi.org/10.2337/db10-0630
[20] Serr, I., Drost, F., Schubert, B. and Daniel, C. (2021) Antigen-Specific Treg Therapy in Type 1 Diabetes – Challenges and Opportunities. Frontiers in Immunology, Volume 12-2021. https://www.frontiersin.org/ journals/immunology/articles/10.3389/fimmu.2021.712870
[21] Warshauer, J.T., Bluestone, J.A. and Anderson, M.S. (2020) New Frontiers in the Treatment of Type 1 Diabetes. Cell Metabolism, 31(1), 46–61. https://doi.org/10.1016/j.cmet.2019.11.017
[22] Ngoenkam, J., Schamel, W.W. and Pongcharoen, S. (2018) Selected signalling proteins recruited to the T-cell receptor–CD3 complex. Immunology, 153(1), 42–50. https://doi.org/10.1111/imm.12809
[23] Straus, D.B., Chan, A.C., Patai, B. and Weiss, A. (1996) SH2 Domain Function Is Essential for the Role of the Lck Tyrosine Kinase in T Cell Receptor Signal Transduction (∗). Journal of Biological Chemistry, 271(17), 9976–9981. https://doi.org/10.1074/jbc.271.17.9976
[24] Isakov, N., Wange, R.L., Burgess, W.H., Watts, J.D., Aebersold, R. and Samelson, L.E. (1995) ZAP-70 binding specificity to T cell receptor tyrosine-based activation motifs: the tandem SH2 domains of ZAP-70 bind distinct tyrosine-based activation motifs with varying affinity. Journal of Experimental Medicine, 181(1), 375–380. https://doi.org/10.1084/jem.181.1.375
[25] Paensuwan, P., Hartl, F.A., Yousefi, O.S., Ngoenkam, J., Wipa, P., Beck-Garcia, E., Dopfer, E.P., Khamsri, B., Sanguansermsri, D., Minguet, S., Schamel, W.W. and Pongcharoen, S. (2016) Nck Binds to the T Cell Antigen Receptor Using Its SH3.1 and SH2 Domains in a Cooperative Manner, Promoting TCR Functioning. The Journal of Immunology, 196(1), 448–458. https://doi.org/10.4049/ jimmunol.1500958
[26] Paensuwan, P., Hartl, F.A., Yousefi, O.S., Ngoenkam, J., Wipa, P., Beck-Garcia, E., Dopfer, E.P., Khamsri, B., Sanguansermsri, D., Minguet, S., Schamel, W.W. and Pongcharoen, S. (2016) Correction: Nck Binds to the T Cell Antigen Receptor Using Its SH3.1 and SH2 Domains in a Cooperative Manner, Promoting TCR Functioning. The Journal of Immunology, 196(11), 4833–4833. https://doi.org/10.4049/ jimmunol.1600551
[27] Ngoenkam, J., Paensuwan, P., Preechanukul, K., Khamsri, B., Yiemwattana, I., Beck-García, E., Minguet, S., Schamel, W.W. and Pongcharoen, S. (2014) Non-overlapping functions of Nck1 and Nck2 adaptor proteins in T cell activation. Cell Communication and Signaling, 12(1), 21. https://doi.org/10.1186/1478-811X-12-21
[28] Ngoenkam, J., Paensuwan, P., Preechanukul, K., Khamsri, B., Yiemwattana, I., Beck-García, E., Minguet, S., Schamel, W.W. and Pongcharoen, S. (2014) Non-overlapping functions of Nck1 and Nck2 adaptor proteins in T cell activation. Cell Communication and Signaling, 12(1), 21. https://doi.org/10.1186/1478-811X-12-21
[29] Richter, K., Rufer, A.C., Muller, M., Burger, D., Casagrande, F., Grossenbacher, T., Huber, S., Hug, M.N., Koldewey, P., D’Osualdo, A., Schlatter, D., Stoll, T. and Rudolph, M.G. (2020) Small molecule AX-024 reduces T cell proliferation independently of CD3ϵ/Nck1 interaction, which is governed by a domain swap in the Nck1-SH3.1 domain. Journal of Biological Chemistry, 295(23), 7849–7864. https://doi.org/ 10.1074/jbc.RA120.012788
[30] Alarcon, B. and Borroto, A. (2020) Small molecule AX-024 targets T cell receptor signaling by disrupting CD3e-Nck interaction. Journal of Biological Chemistry, 295(29), 10076. https://doi.org/10.1074/ jbc.l120.014338
[31] Richter, K., Rufer, A.C., Muller, M., Burger, D., Casagrande, F., Grossenbacher, T., Huber, S., Hug, M.N., Koldewey, P., D’Osualdo, A., Schlatter, D., Stoll, T. and Rudolph, M.G. (2020) Reply to Alarcon and Borroto: Small molecule AX-024 reduces T cell proliferation independently of CD3ε-Nck1 interaction at SH3.1. The Journal of biological chemistry, 295(29), 10077. https://doi.org/10.1074/jbc.RL120.014441
[32] Juraske, C., Wipa, P., Morath, A., Hidalgo, J.V., Hartl, F.A., Raute, K., Oberg, H.-H., Wesch, D., Fisch, P., Minguet, S., Pongcharoen, S. and Schamel, W.W. (2018) Anti-CD3 Fab Fragments Enhance Tumor Killing by Human γδ T Cells Independent of Nck Recruitment to the γδ T Cell Antigen Receptor. Frontiers in Immunology, Volume 9-2018. https://www.frontiersin.org/journals/immunology/articles/10.3389/ fimmu.2018.01579
[33] Ramírez, Y., Laguna, M.F. and Holgado, M. (2022) New Label-Free Biosensing for the Evaluation of the AX-024 Inhibitor: Case Study for the Development of New Drugs in Autoimmune Diseases. Sensors, 22(3). https://doi.org/10.3390/s22031218
[34] Sadybekov, A.V. and Katritch, V. (2023) Computational approaches streamlining drug discovery. Nature, 616(7958), 673–685. https://doi.org/10.1038/s41586-023-05905-z
[35] Durrant, J.D. and McCammon, J.A. (2011) Molecular dynamics simulations and drug discovery. BMC Biology, 9(1), 71. https://doi.org/10.1186/1741-7007-9-71
[36] Ghattas, M.A., Al Rawashdeh, S., Atatreh, N. and Bryce, R.A. (2020) How Do Small Molecule Aggregates Inhibit Enzyme Activity? A Molecular Dynamics Study. Journal of Chemical Information and Modeling, 60(8), 3901–3909. https://doi.org/10.1021/acs.jcim.0c00540
[37] Santos, L.H.S., Ferreira, R.S. and Caffarena, E.R. (2019) Integrating Molecular Docking and Molecular Dynamics Simulations. In W.F. de Azevedo Jr., ed. Docking Screens for Drug Discovery. New York, NY: Springer New York. 13–34. https://doi.org/10.1007/978-1-4939-9752-7_2
[38] Guan, S., Wang, T., Kuai, Z., Qian, M., Tian, X., Zhang, X., Yu, Y., Wang, S., Zhang, H., Li, H., Kong, W. and Shan, Y. (2017) Exploration of binding and inhibition mechanism of a small molecule inhibitor of influenza virus H1N1 hemagglutinin by molecular dynamics simulation. Scientific Reports, 7(1), 3786. https://doi.org/10.1038/s41598-017-03719-4
[39] Alonso, H., Bliznyuk, A.A. and Gready, J.E. (2006) Combining docking and molecular dynamic simulations in drug design. Medicinal Research Reviews, 26(5), 531–568. https://doi.org/10.1002/ med.20067
[40] Vidal-Limon, A., Aguilar-Toalá, J.E. and Liceaga, A.M. (2022) Integration of Molecular Docking Analysis and Molecular Dynamics Simulations for Studying Food Proteins and Bioactive Peptides. Journal of Agricultural and Food Chemistry, 70(4), 934–943. https://doi.org/10.1021/acs.jafc.1c06110
[41] Pathak, R.K., Kim, W.-I. and Kim, J.-M. (2023) Targeting the PEDV 3CL protease for identification of small molecule inhibitors: an insight from virtual screening, ADMET prediction, molecular dynamics, free energy landscape, and binding energy calculations. Journal of Biological Engineering, 17(1), 29. https://doi.org/10.1186/s13036-023-00342-y
[42] Landrum, G., Tosco, P., Kelley, B., Rodriguez, R., Cosgrove, D., Vianello, R., sriniker, Gedeck, P., Jones, G., Kawashima, E., NadineSchneider, Nealschneider, D., Dalke, A., tadhurst-cdd, Swain, M., Cole, B., Turk, S., Savelev, A., Vaucher, A., Wójcikowski, M., Take, I., Faara, H., Scalfani, V.F., Walker, R., Probst, D., Ujihara, K., Maeder, N., Monat, J., Lehtivarjo, J. and godin, guillaume (2025) rdkit/rdkit: 2025_03_5 (Q1 2025) Release. Zenodo. https://doi.org/10.5281/zenodo.16439048
[43] Baell, J.B. and Holloway, G.A. (2010) New Substructure Filters for Removal of Pan Assay Interference Compounds (PAINS) from Screening Libraries and for Their Exclusion in Bioassays. Journal of Medicinal Chemistry, 53(7), 2719–2740. https://doi.org/10.1021/jm901137j
[44] Baell, J. and Walters, M.A. (2014) Chemistry: Chemical con artists foil drug discovery. Nature, 513(7519), 481–483. https://doi.org/10.1038/513481a
[45] Trott, O. and Olson, A.J. (2010) AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. Journal of Computational Chemistry, 31(2), 455–461. https://doi.org/10.1002/jcc.21334
[46] Eberhardt, J., Santos-Martins, D., Tillack, A.F. and Forli, S. (2021) AutoDock Vina 1.2.0: New Docking Methods, Expanded Force Field, and Python Bindings. Journal of Chemical Information and Modeling, 61(8), 3891–3898. https://doi.org/10.1021/acs.jcim.1c00203
[47] Forli, S., Huey, R., Pique, M.E., Sanner, M.F., Goodsell, D.S. and Olson, A.J. (2016) Computational protein–ligand docking and virtual drug screening with the AutoDock suite. Nature Protocols, 11(5), 905–919. https://doi.org/10.1038/nprot.2016.051
[48] Abraham, M., Alekseenko, A., Basov, V., Bergh, C., Briand, E., Brown, A., Doijade, M., Fiorin, G., Fleischmann, S., Gorelov, S., Gouaillardet, G., Gray, A., Irrgang, M.E., Jalalypour, F., Jordan, J., Kutzner, C., Lemkul, J.A., Lundborg, M., Merz, P., Miletic, V., Morozov, D., Nabet, J., Pall, S., Pasquadibisceglie, A., Pellegrino, M., Santuz, H., Schulz, R., Shugaeva, T., Shvetsov, A., Villa, A., Wingbermuehle, S., Hess, B. and Lindahl, E. (2024) GROMACS 2024.4 Manual. Zenodo. https://doi.org/10.5281/zenodo.14016613
[49] Hornak, V., Abel, R., Okur, A., Strockbine, B., Roitberg, A. and Simmerling, C. (2006) Comparison of multiple Amber force fields and development of improved protein backbone parameters. Proteins: Structure, Function, and Bioinformatics, 65(3), 712–725. https://doi.org/10.1002/prot.21123
[50] Wang, J., Wolf, R.M., Caldwell, J.W., Kollman, P.A. and Case, D.A. (2004) Development and testing of a general amber force field. Journal of Computational Chemistry, 25(9), 1157–1174. https://doi.org/ https://doi.org/10.1002/jcc.20035
[51] Casoria, M., Macchiagodena, M., Rovero, P., Andreini, C., Papini, A.M., Cardini, G. and Pagliai, M. (2024) Upgrading of the general AMBER force field 2 for fluorinated alcohol biosolvents: A validation for water solutions and melittin solvation. Journal of Peptide Science, 30(2), e3543. https://doi.org/ https://doi.org/10.1002/psc.3543
[52] Jorgensen, W.L., Chandrasekhar, J., Madura, J.D., Impey, R.W. and Klein, M.L. (1983) Comparison of simple potential functions for simulating liquid water. The Journal of Chemical Physics, 79(2), 926–935. https://doi.org/10.1063/1.445869
[53] Darden, T., York, D. and Pedersen, L. (1993) Particle mesh Ewald: An N⋅log(N) method for Ewald sums in large systems. The Journal of Chemical Physics, 98(12), 10089–10092. https://doi.org/10.1063/ 1.464397
[54] Hess, B., Bekker, H., Berendsen, H.J.C. and Fraaije, J.G.E.M. (1997) LINCS: A linear constraint solver for molecular simulations. Journal of Computational Chemistry, 18(12), 1463–1472. https://doi.org/ 10.1002/ (SICI)1096-987X(199709)18:12%3C1463::AID-JCC4%3E3.0.CO;2-H
[55] Miller, B.R. 3rd, McGee, T.D.J., Swails, J.M., Homeyer, N., Gohlke, H. and Roitberg, A.E. (2012) MMPBSA.py: An Efficient Program for End-State Free Energy Calculations. Journal of chemical theory and computation, 8(9), 3314–3321. https://doi.org/10.1021/ct300418h
[56] Valdés-Tresanco, M.S., Valdés-Tresanco, M.E., Valiente, P.A. and Moreno, E. (2021) gmx_MMPBSA: A New Tool to Perform End-State Free Energy Calculations with GROMACS. Journal of Chemical Theory and Computation, 17(10), 6281–6291. https://doi.org/10.1021/acs.jctc.1c00645
[57] Gowers, R.J., Linke, M., Barnoud, J., Reddy, T.J.E., Melo, M.N., Seyler, S.L., Domański, J., Dotson, D.L., Buchoux, S., Kenney, I.M. and Beckstein, O. (2016) MDAnalysis: A Python Package for the Rapid Analysis of Molecular Dynamics Simulations. In S. Benthall and S. Rostrup, eds. Proceedings of the 15th Python in Science Conference. 98–105. https://doi.org/10.25080/Majora-629e541a-00e
[58] Michaud-Agrawal, N., Denning, E.J., Woolf, T.B. and Beckstein, O. (2011) MDAnalysis: A toolkit for the analysis of molecular dynamics simulations. Journal of Computational Chemistry, 32(10), 2319–2327. https://doi.org/10.1002/jcc.21787
[59] Schrödinger Release 2025-3: Maestro (2025) New York, NY: Schrödinger, LLC.
[60] Weininger, D. (1988) SMILES, a chemical language and information system. 1. Introduction to methodology and encoding rules. Journal of Chemical Information and Computer Sciences, 28(1), 31–36. https://doi.org/10.1021/ci00057a005
[61] Weininger, D., Weininger, A. and Weininger, J.L. (1989) SMILES. 2. Algorithm for generation of unique SMILES notation. Journal of Chemical Information and Computer Sciences, 29(2), 97–101. https://doi.org/10.1021/ci00062a008
[62] Weininger, D. (1990) SMILES. 3. DEPICT. Graphical depiction of chemical structures. Journal of Chemical Information and Computer Sciences, 30(3), 237–243. https://doi.org/10.1021/ci00067a005
[63] Xie, S., Zhu, H. and Huang, N. (2025) AI-Designed Molecules in Drug Discovery, Structural Novelty Evaluation, and Implications. Journal of Chemical Information and Modeling, 65(17), 8924–8933. https://doi.org/10.1021/acs.jcim.5c00921
[64] Bertazzo, M., Gobbo, D., Decherchi, S. and Cavalli, A. (2021) Machine Learning and Enhanced Sampling Simulations for Computing the Potential of Mean Force and Standard Binding Free Energy. Journal of Chemical Theory and Computation, 17(8), 5287–5300. https://doi.org/10.1021/acs.jctc.1c00177
Downloads
Published
Issue
Section
License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
